SciNX | Universal exosome production as well as batch culture medium

CHF 49.00CHF 55.00

SKU: 100130-1 Category: Tags: , ,

SciNX enables the growth of various adherent cell lines as well as the propagation of suspension cell lines such as CHO-K1 or glioblastoma after a short direct adaptation phase.

This animal component-free medium was initially designed to provide a serum-free solution to produce exosomes in various adherent cell lines. Once applied, exosome production can be prologed for up to 6-7 days. Several serial incubation steps are beneficial to generate a homogeneous exosome population without FCS-derived contaminations.

The chemically defined, protein-free formulation provides essential as well as beneficial nutrients and is free of any animal-derived component.

Note: Depending on the cell type or cell line, the addition of specific growth factors is necessary.

__________________________________________________________________________________________________________

Application note | Characteristics

SciNX is available in different formates:

  • w/o L-glutamine
  • with L-glutamine
  • Powder for 1 L SciNX (w/o L-glutamine, w/o D-(+)-glucose, w/o NaHCO3)

 

SciNX contains neither phenol red, antibiotics nor poloxamer 188.
The formulation contains an optimised nucleoside composition.

On request, variations in media formulation can be performed.

The medium is provided as a 0.22 μm sterile filtered as well as sterility tested liquid with a pH of 7.3 +/- 0.1 and free of mycoplasma.

__________________________________________________________________________________________________________

Compatible cell lines

  • CHO-K1
  • Various human cancer cell lines
  • Exosome production in various cancer cell lines

__________________________________________________________________________________________________________

Additional information

Data sheet SciNX

Protocol SciNX Adaptation

Reviews

Be the first to review “SciNX | Universal exosome production as well as batch culture medium”

Your email address will not be published. Required fields are marked *